Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

The top-seeded Newman boys soccer team is headed back to the Division IV championship.

KR Choksey is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2472 in its research report dated February 13, 2025.

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

IST, the benchmark BSE Sensex was down by 458.50 points or 0.60%, reaching 75,680.47. The broader NSE Nifty was 165.80 points ...

Trump announced reciprocal tariffs that could take effect against US trading partners, including India, as soon as April. The ...

Samsung updated its Galaxy S series in January, and now it’s time for the A-series to get the same treatment. While the ...

The Samsung Galaxy A26s renders reveal a flat display with a waterdrop-style notch at the front. Heres everything you should ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

Glenmark Pharmaceuticals launches a generic ophthalmic solution for glaucoma in the US market, adding to its growing ...

IST, the barometer index, the S&P BSE Sensex, slipped 441.78 points or 0.58% to 75,697.19. The Nifty 50 index declined 165.80 points or 0.72% to 22,865.60.